- Home
- FOF vs QTRX Comparison
FOF vs QTRX Comparison
Compare FOF & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOF | QTRX |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.4M | 160.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | FOF | QTRX |
|---|---|---|
| Price | $14.14 | $2.69 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 46.6K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | N/A | $10.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $11.82 | $2.56 |
| 52 Week High | $15.04 | $8.77 |
Technical Indicators
Market Signals| Indicator | FOF | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 63.23 | 32.11 |
| Support Level | $14.07 | N/A |
| Resistance Level | $14.50 | $3.81 |
| Average True Range (ATR) | 0.22 | 0.29 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 72.78 | 16.02 |
Price Performance
Historical ComparisonAbout FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. The Fund's investment objective is to achieve total return, consisting of high current income and potential capital appreciation.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.